When to increase a testosterone dose, or stay on it

Reviewed 12 sourcesPublished by PepVault

What each testosterone label says about dose changes: when the blood is drawn, the level that means up, stay or down, and the hematocrit line that pauses it.

A couple cook at a kitchen island, he hands her a slice of red pepper and they laugh
Last reviewed
Sources
12
Questions
8

The short answer

On FDA-approved testosterone, the prescriber moves the dose from a blood test timed to that product, not by feel. AndroGel 1.62% and Testim are checked before the morning dose about 14 days in; weekly Xyosted at its low point after 6 weeks. AndroGel 1.62% goes up below 350 ng/dL, stays from 350 to 750 and comes down above 750. The Endocrine Society pauses treatment above a 54% hematocrit.

Every number checked at its primary source · · 12 sources · How we research

Evidence: FDA prescribing information for eleven testosterone products and the Endocrine Society's 2018 guideline; the four titration trials behind the labels' bands ran 150 to 274 men, three of them open-label.

A couple cook at a kitchen island, he hands her a slice of red pepper and they laugh

When does a testosterone dose go up, stay or come down?

Every label that adjusts the dose works the same way: start at a set dose, measure the level at a time the label names, then step up, stay or step down. That is titration (pepvault.app/glossary/titration). What differs is the time of the draw and the numbers, because a gel, a weekly shot and a capsule each make a different curve.

Product (form)Label's starting doseWhen the blood is drawnUpStayDown or stop
AndroGel 1.62% (gel, daily)40.5 mg each morningBefore the morning dose, about 14 and 28 days after starting or any change1Under 350 ng/dL: 20.25 mg up, to 81 mg at most1350 to 750 ng/dL1Over 750 ng/dL: 20.25 mg down1
AndroGel 1% (gel, daily)50 mg each morningAt intervals2Below normal: to 75 mg, then 100 mg2Normal range2Above normal: lower; consistently above on 50 mg: stop2
Testim (gel, daily)50 mg (one tube)Before the morning dose, about 14 days in3Below 300 ng/dL: 100 mg, the maximum3300 to 1,000 ng/dL3None given3
Xyosted (shot under the skin, weekly)75 mgThe trough, 7 days after a dose, at 6 weeks and 6 weeks after any change4Under 350 ng/dL: 25 mg up4350 to under 650 ng/dL4650 ng/dL or more: 25 mg down4
Jatenzo (capsule, twice daily)237 mg6 hours after the morning dose, 7 or more days after a start or change5Under 425 ng/dL: one step up, to 396 mg5425 to 970 ng/dL5Over 970 ng/dL: one step down; already at 158 mg: stop5
Kyzatrex (capsule, twice daily)200 mg3 to 5 hours after the morning dose, 7 or more days after a start or change6Under 460 ng/dL: one step up, to 400 mg6460 to 971 ng/dL6Over 971 ng/dL: one step down; already at 100 mg once daily: stop6
Tlando (capsule, twice daily)225 mg, fixed8 to 9 hours after the morning dose, at 3 to 4 weeks7No up step7300 to 1,080 ng/dL7Outside that: stop7
Natesto (nasal gel, three times daily)11 mg each timePeriodically, from 1 month8No up step; consistently under 300 ng/dL: another treatment8In range8Consistently over 1,050 ng/dL: stop8
Aveed (shot into the muscle)750 mg at start, at 4 weeks, then every 10 weeksThe label sets none: titration "is not necessary"9None9Fixed9None9
Cypionate or enanthate (shot into the muscle)50 to 400 mg every 2 to 4 weeks1011Not in the labels; the guideline: midway between shots12Under 350 ng/dL: change dose or interval12350 to 600 ng/dL12Over 600 ng/dL: change dose or interval12

Three products never move the dose: Aveed is fixed, and on Tlando and Natesto a level out of range means stopping or another treatment789. Testosterone against the options that raise a man's own production: pepvault.app/guides/raising-testosterone-trt-vs-others.

These are the prescriber's rules, told so you know what your results are read against; the decision is the prescriber's, not a plan for changing a dose yourself. Doses do not carry over one for one between products: the gel labels and the oral undecanoate labels each say so12367.

PepVault logs each dose with the time you took it, so when the lab asks how long ago your last shot or morning dose was, the answer is on your log. Log it in PepVault

A smiling woman in a blue top leaning on her kitchen counter with her phone and a notebook

PepVault for iPhone

Keep your protocol in PepVault

PepVault logs each dose with the time you took it, so when the lab asks how long ago your last shot or morning dose was, the answer is on your log.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Why does the time of the blood draw change the number?

Testosterone rises after each dose and falls until the next, so one man can read high or low by the hour. Xyosted is checked at its trough, the last point before the next shot, and its label says a trough of 350 to 650 ng/dL generally keeps the whole week in the normal range4. The capsules are checked hours after the morning dose, against bands of their own567.

The guideline and the labels do not always pick the same moment. For gels, the Endocrine Society measures 2 to 8 hours after the application, once a man has used it for at least a week, where AndroGel 1.62% and Testim draw before the morning dose1312. The prescriber names which one a result is read against.

Injected esters stretch the curve further. Testosterone cypionate has a half-life (pepvault.app/glossary/half-life) of about eight days after an injection into the muscle10, so a level two days after a shot and one the day before the next can read very differently. The chart below shows that rise and fall.

Try it

How Testosterone Cypionate builds up

An estimate from a half-life of about 8 days, one dose a week for four weeks. The shape of the level, not a measurement.

Try your own schedule

How long after starting or changing a dose is testosterone rechecked?

Each label waits for a new dose to settle before reading the level: at least 7 days for Jatenzo and Kyzatrex56, about 14 days for AndroGel 1.62% and Testim13, 3 to 4 weeks for Tlando7, and 6 weeks for Xyosted, the week its trial reached steady state (pepvault.app/glossary/steady-state), when each week's curve repeats the last4. After a change, the wait starts again.

The Endocrine Society's 2018 guideline sets the wider schedule: testosterone measured 3 to 6 months after starting, aiming at the middle of the normal range, and the man reviewed at 3 to 12 months and then yearly for whether his symptoms responded and for side effects12.

How do you get a blood test the dose decision can use?

  1. Ask your prescriber which reading your product's rule uses: before the morning dose, hours after it, the trough before the next shot, or midway between shots.
  2. Book the draw for the day your label sets: 7 days, about 14 days or 6 weeks after starting or the last change145.
  3. Keep to your prescribed schedule in the days before, so the test reads your usual pattern.
  4. Write down when you took the last dose and when the blood was drawn; capsule bands depend on the hours between67.
  5. Use the same lab each time where you can.
  6. Bring a note on how you have felt since the change; the guideline reviews symptoms beside the number12.

What do the cypionate and enanthate shots go by?

The older intramuscular shots carry no target and no draw time. The Depo-Testosterone label says the dose "is adjusted according to the patient's response and the appearance of adverse reactions"10; the enanthate label adds that more than 400 mg a month is generally not required and that shots more often than every two weeks are rarely indicated11.

The Endocrine Society fills the gap with the midway reading in the table above, and it can change how often the shots come as well as the amount12.

How often does titration land in the normal range?

Most men ended in range, and many moved off the starting dose to get there. In the AndroGel 1.62% trial, everyone started on 40.5 mg and was checked on days 14, 28 and 42; by day 112, 133 of the 179 men counted on active gel were on 60.75 or 81 mg, and only 12 ended on the lowest step1.

Label's trialMenDesignIn the normal range after titration
AndroGel 1.62%274 (234 on gel; 179 counted at day 112)Randomized, double-blind, placebo-controlled81.6% at day 112; 78% at one year1
Xyosted150Open-label, one year90% at week 12 (300 to 1,100 ng/dL), none above 1,5004
Jatenzo166Open-label, about 4 months87% at the end of treatment5
Kyzatrex155 (139 in the efficacy count)Open-label, about 6 months88% at day 90 (222 to 800 ng/dL)6

Each trial used its own normal range, so the figures do not rank the products.

What does hematocrit have to do with the dose?

Testosterone raises red blood cell production, so hematocrit, the share of the blood made of red cells, rises; more red cells may raise clot risk, and the labels pause the dose for it4. The gel labels check it before starting, 3 to 6 months in and then yearly; Xyosted, Jatenzo and Kyzatrex about every 3 months; Tlando every 3 months in year one, then every 614567.

When it climbs, the labels stop treatment until it comes down to an acceptable level134; on Xyosted, Jatenzo, Kyzatrex and Tlando a second rise after a restart stops it for good4567. The Endocrine Society puts a number on it: above 54%, stop until it is safe, look for low oxygen and sleep apnea, then restart at a lower dose; above 48% before starting (50% at high altitude) is itself a reason for caution12.

Commonly reported: in Xyosted's one-year study of 150 men, a rising hematocrit was the most frequent side effect (14%), ahead of high blood pressure (12.7%) and a rising PSA (12%); across its two studies, 4.2% of 283 men reached a hematocrit of 55% or more4.

When to get help Pain, swelling or redness in a leg, chest pain or shortness of breath while on testosterone can be signs of a clot, and the Jatenzo label says to report them promptly and seek urgent care5.

What else is checked at the dose visits?

  • PSA (prostate-specific antigen): for men 55 to 69, or 40 to 69 at higher risk, who choose prostate monitoring, checked before starting and at 3 to 12 months; a rise of more than 1.4 ng/mL in the first year, or a confirmed level above 4, means a urologist12.
  • Blood pressure: Jatenzo raised average 24-hour blood pressure by 4.9/2.5 mm Hg after about four months, and its label asks for periodic checks5.
  • Hemoglobin and cholesterol: Aveed's label lists PSA, hemoglobin, hematocrit and lipids for periodic checks, and Depo-Testosterone's lists hemoglobin with hematocrit910.
  • Symptoms and side effects, reviewed at 3 to 12 months and then yearly12.

PepVault's bloodwork log has total and free testosterone, estradiol, hemoglobin and hematocrit built in, and PSA goes in as a custom marker, so each panel lines up beside the last one before your next visit. Log it in PepVault

Levels before treatment, by age: pepvault.app/guides/testosterone-levels-by-age. The labs before a first dose: pepvault.app/guides/blood-tests-before-starting.

Track it in the app

Sources

  1. AndroGel 1.62% (testosterone gel). Prescribing information, Ascend Therapeutics. DailyMed, label version of October 22, 2025. dailymed.nlm.nih.gov
  2. AndroGel 1% (testosterone gel). Prescribing information, Ascend Therapeutics. DailyMed, label version of July 31, 2025. dailymed.nlm.nih.gov
  3. Testim (testosterone gel). Prescribing information, Endo. DailyMed, label version of July 15, 2025. dailymed.nlm.nih.gov
  4. Xyosted (testosterone enanthate) injection. Prescribing information, Antares Pharma. DailyMed, label version of July 1, 2025. dailymed.nlm.nih.gov
  5. Jatenzo (testosterone undecanoate) capsules. Prescribing information, Tolmar. DailyMed, label version of October 13, 2026. dailymed.nlm.nih.gov
  6. Kyzatrex (testosterone undecanoate) capsules. Prescribing information, Marius Pharmaceuticals. DailyMed, label version of October 5, 2026. dailymed.nlm.nih.gov
  7. Tlando (testosterone undecanoate) capsules. Prescribing information, Verity Pharmaceuticals. DailyMed, label version of February 25, 2026. dailymed.nlm.nih.gov
  8. Natesto (testosterone) nasal gel. Prescribing information, Acerus Pharmaceuticals. DailyMed, label version of July 22, 2025. dailymed.nlm.nih.gov
  9. Aveed (testosterone undecanoate) injection. Prescribing information, Endo. DailyMed, label version of July 15, 2025. dailymed.nlm.nih.gov
  10. Depo-Testosterone (testosterone cypionate) injection. Prescribing information, Pfizer (Pharmacia & Upjohn), revised October 2025. DailyMed, label version of November 10, 2026. dailymed.nlm.nih.gov
  11. Testosterone enanthate injection. Prescribing information, Hikma Pharmaceuticals. DailyMed, label version of May 8, 2026. dailymed.nlm.nih.gov
  12. Bhasin S et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744 (recommendation 3 and its monitoring table). PubMed 29562364

Newsletter · Weekly

The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

We’ll email you a link to confirm. Your address is used for the briefing only. Privacy

PepVault for iPhone

Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo